Literature DB >> 16803468

Which drugs cause preventable admissions to hospital? A systematic review.

R L Howard1, A J Avery, S Slavenburg, S Royal, G Pipe, P Lucassen, M Pirmohamed.   

Abstract

AIMS: Previous systematic reviews have found that drug-related morbidity accounts for 4.3% of preventable hospital admissions. None, however, has identified the drugs most commonly responsible for preventable hospital admissions. The aims of this study were to estimate the percentage of preventable drug-related hospital admissions, the most common drug causes of preventable hospital admissions and the most common underlying causes of preventable drug-related admissions.
METHODS: Bibliographic databases and reference lists from eligible articles and study authors were the sources for data. Seventeen prospective observational studies reporting the proportion of preventable drug-related hospital admissions, causative drugs and/or the underlying causes of hospital admissions were selected. Included studies used multiple reviewers and/or explicit criteria to assess causality and preventability of hospital admissions. Two investigators abstracted data from all included studies using a purpose-made data extraction form.
RESULTS: From 13 papers the median percentage of preventable drug-related admissions to hospital was 3.7% (range 1.4-15.4). From nine papers the majority (51%) of preventable drug-related admissions involved either antiplatelets (16%), diuretics (16%), nonsteroidal anti-inflammatory drugs (11%) or anticoagulants (8%). From five studies the median proportion of preventable drug-related admissions associated with prescribing problems was 30.6% (range 11.1-41.8), with adherence problems 33.3% (range 20.9-41.7) and with monitoring problems 22.2% (range 0-31.3).
CONCLUSIONS: Four groups of drugs account for more than 50% of the drug groups associated with preventable drug-related hospital admissions. Concentrating interventions on these drug groups could reduce appreciably the number of preventable drug-related admissions to hospital from primary care.

Mesh:

Year:  2006        PMID: 16803468      PMCID: PMC2000562          DOI: 10.1111/j.1365-2125.2006.02698.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  29 in total

1.  Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study.

Authors:  C F Green; D R Mottram; P H Rowe; M Pirmohamed
Journal:  J Clin Pharm Ther       Date:  2000-10       Impact factor: 2.512

2.  Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies.

Authors:  H J M Beijer; C J de Blaey
Journal:  Pharm World Sci       Date:  2002-04

3.  Preventable drug-related hospital admissions.

Authors:  Almut G Winterstein; Brian C Sauer; Charles D Hepler; Charles Poole
Journal:  Ann Pharmacother       Date:  2002 Jul-Aug       Impact factor: 3.154

4.  Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention.

Authors:  J Hallas; B Harvald; L F Gram; E Grodum; K Brøsen; T Haghfelt; N Damsbo
Journal:  J Intern Med       Date:  1990-08       Impact factor: 8.989

5.  Identifying hospital admissions due to adverse drug events using a computer-based monitor.

Authors:  A K Jha; G J Kuperman; E Rittenberg; J M Teich; D W Bates
Journal:  Pharmacoepidemiol Drug Saf       Date:  2001 Mar-Apr       Impact factor: 2.890

6.  Randomised controlled trial of specialist nurse intervention in heart failure.

Authors:  L Blue; E Lang; J J McMurray; A P Davie; T A McDonagh; D R Murdoch; M C Petrie; E Connolly; J Norrie; C E Round; I Ford; C E Morrison
Journal:  BMJ       Date:  2001-09-29

7.  Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility.

Authors:  J Bigby; J Dunn; L Goldman; J B Adams; P Jen; C S Landefeld; A L Komaroff
Journal:  Am J Med       Date:  1987-12       Impact factor: 4.965

8.  Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use.

Authors:  Kam Chuen Lai; Shiu Kum Lam; Kent Man Chu; Benjamin C Y Wong; Wai Mo Hui; Wayne H C Hu; George K K Lau; Wai Man Wong; Man Fung Yuen; Annie O O Chan; Ching Lung Lai; John Wong
Journal:  N Engl J Med       Date:  2002-06-27       Impact factor: 91.245

Review 9.  Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors.

Authors:  C J Hawkey; M J S Langman
Journal:  Gut       Date:  2003-04       Impact factor: 23.059

10.  Hospital admissions resulting from preventable adverse drug reactions.

Authors:  Patrick J McDonnell; Michael R Jacobs
Journal:  Ann Pharmacother       Date:  2002-09       Impact factor: 3.154

View more
  216 in total

1.  DOCUMENT: a system for classifying drug-related problems in community pharmacy.

Authors:  Mackenzie Williams; Gregory M Peterson; Peter C Tenni; Ivan K Bindoff; Andrew C Stafford
Journal:  Int J Clin Pharm       Date:  2011-11-19

2.  Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans.

Authors:  Zachary A Marcum; Mary Jo V Pugh; Megan E Amuan; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Joseph T Hanlon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

3.  Adverse drug reactions in a population of hospitalized very elderly patients.

Authors:  Balamurugan Tangiisuran; J Graham Davies; Juliet E Wright; Chakravarthi Rajkumar
Journal:  Drugs Aging       Date:  2012-08-01       Impact factor: 3.923

4.  Preventable drug-related morbidity in community pharmacy: commentary on the implications for practice and policy of a novel intervention.

Authors:  Mara Pereira Guerreiro; Ana Paula Martins; Judith Anne Cantrill
Journal:  Int J Clin Pharm       Date:  2012-07-10

5.  Ten-year trends in hospital admissions for adverse drug reactions in England 1999-2009.

Authors:  Tai-Yin Wu; Min-Hua Jen; Alex Bottle; Mariam Molokhia; Paul Aylin; Derek Bell; Azeem Majeed
Journal:  J R Soc Med       Date:  2010-06       Impact factor: 5.344

6.  Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies.

Authors:  Priya Bahri
Journal:  Drug Saf       Date:  2010-12-01       Impact factor: 5.606

Review 7.  Predicting risk of adverse drug reactions in older adults.

Authors:  Amanda Hanora Lavan; Paul Gallagher
Journal:  Ther Adv Drug Saf       Date:  2016-02

8.  Effects of medication review on drug-related problems in patients using automated drug-dispensing systems: a pragmatic randomized controlled study.

Authors:  Henk Frans Kwint; Adrianne Faber; Jacobijn Gussekloo; Marcel L Bouvy
Journal:  Drugs Aging       Date:  2011-04-01       Impact factor: 3.923

9.  Antihypertensive-related adverse drug reactions among older hospitalized adults.

Authors:  Tariq M Alhawassi; Ines Krass; Lisa G Pont
Journal:  Int J Clin Pharm       Date:  2018-02-01

10.  Impact of non-interruptive medication laboratory monitoring alerts in ambulatory care.

Authors:  Helen G Lo; Michael E Matheny; Diane L Seger; David W Bates; Tejal K Gandhi
Journal:  J Am Med Inform Assoc       Date:  2008-10-24       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.